Bifogade filer
Beskrivning
Land | Norge |
---|---|
Lista | OB Match |
Sektor | Hälsovård |
Industri | Bioteknik |
NOT FOR DISTRIBUTION OR RELEASE, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES OF AMERICA, THE UNITED KINGDOM, AUSTRALIA, CANADA, HONG KONG OR JAPAN, OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL. THIS ANNOUNCEMENT DOES NOT CONSTITUTE AN OFFER OF ANY OF THE SECURITIES DESCRIBED HEREIN.
Oslo, Norway, 15 December 2024: Reference is made to the rights issue by Circio Holding ASA (the "Company") completed in July 2024 (the "Rights Issue").
Due to substantial interest from existing shareholders and new investors for the ongoing Warrants exercise, the board of directors of the Company has resolved to open for subscription of additional new shares at an issue price of NOK 0.60 (i.e. equal to the Warrant Exercise Price).
A total of 13,864,852 warrants (Nw.: frittstående tegningsretter) (the "Warrants") were issued in connection with the Rights Issue. Each Warrant gives the holder (the "Holder") a right to subscribe for one new share in the Company at an exercise price per share of NOK 0.60 (the "Warrant Exercise Price"). The Warrants must be exercised no later than 16:30 (CET) on 18 December 2024 (the "Warrant Expiry Time").
The Company has been informed that certain holders will not exercise their Warrants, including Atlas Special Opportunities LLC ("Atlas") which holds 6 million Warrants. These Warrants have been made available to the Company for distribution for free to investors who contact the Company indicating their interests in acquiring Warrants and who will exercise them prior to the Warrant Expiry Time (the "Potential Investors"). Any funds raised from the exercise of Warrants will reduce and delay the requirement to draw future tranches from Atlas under the convertible bond financing facility.
In the event Potential Investors are interested in exercising more Warrants than those available for distribution by the Company, the board of directors is contemplating carrying out a private placement by the issuance of up to 4,903,934 additional new shares at an issue price of NOK 0.60 per share to satisfy such additional demand by use of the authorization to increase the share capital granted by the general meeting on 19 June 2024.
Potential Investors interested in exercising Warrants and subscribing for new shares are requested to complete an application form (the "Application Form") attached to this notice. The Application Form must be completed and received by the Company by e-mail at contact@circio.com before 16.00 hours (CET) on 17 December 2024.
The minimum exercise and subscription amount per Potential Investor is NOK 50,000, which corresponds to 83,333 shares. The allocation of Warrants and private placement shares among Potential Investors will be at the sole discretion of the Company.
The Company will on 18 December 2024 contact the Potential Investors who are being allocated Warrants and private placement shares to inform them of the number of Warrants and shares allocated to them and provide information on the allocation and total payment information.